Han Caitlin, Manners Melissa T, Robinson Shivon A
Department of Psychology, Williams College, Williamstown, MA, United States.
Department of Biological and Biomedical Sciences, Rowan University, Glassboro, NJ, United States.
Front Pharmacol. 2024 Aug 29;15:1455416. doi: 10.3389/fphar.2024.1455416. eCollection 2024.
Opioid drugs have been long known to induce different responses in males compared to females, however, the molecular mechanisms underlying these effects are yet to be fully characterized. Recent studies have established a link between the gut microbiome and behavioral responses to opioids. Chronic opioid use is associated with gut dysbiosis, or microbiome disruptions, which is thought to contribute to altered opioid analgesia and reward processing. Gut microbiome composition and functioning have also been demonstrated to be influenced by sex hormones. Despite this, there is currently very little work investigating whether sex differences in the gut microbiome mediate sex-dependent responses to opioids, highlighting a critical gap in the literature. Here, we briefly review the supporting evidence implicating a potential role for the gut microbiome in regulating sexually dimorphic opioid response and identify areas for future research.
长期以来,人们已知阿片类药物在男性和女性中会引发不同反应,然而,这些效应背后的分子机制尚未完全明确。最近的研究已在肠道微生物群与对阿片类药物的行为反应之间建立了联系。长期使用阿片类药物与肠道菌群失调或微生物群破坏有关,这被认为会导致阿片类药物镇痛和奖赏处理的改变。肠道微生物群的组成和功能也已被证明受性激素影响。尽管如此,目前很少有研究调查肠道微生物群中的性别差异是否介导了对阿片类药物的性别依赖性反应,这凸显了文献中的一个关键空白。在此,我们简要回顾支持肠道微生物群在调节两性阿片类药物反应中潜在作用的证据,并确定未来研究的领域。